Champions Oncology CSBR
NASDAQ CSBR
$5.01 -0.09 (-1.76%)
As of: Sep 9, 2026 · 3:58 PM EDT

Champions Oncology (CSBR) Net Margin Growth (3y) (2013 - 2026)

Analysis

Champions Oncology (CSBR) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Iqvia Holdings 42.77 Bn 40.69 Bn 1.44 Bn -237.00
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn 391.00
3 Charles River Laboratories International 13.37 Bn 13.18 Bn 452.07 Mn -923.00
4 Icon 12.49 Bn 11.56 Bn 479.29 Mn -273.00
5 Fortrea Holdings 1.58 Bn 1.42 Bn 139.20 Mn -619.00
6 Evotec SE 642.83 Mn 216.96 Mn - -
7 Ginkgo Bioworks Holdings 422.55 Mn 338.02 Mn 18.44 Mn -1,663.00
8 Champions Oncology 69.16 Mn 69.16 Mn 7.03 Mn 1,477.00
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn 5,704.00
10 VivoSim Labs 1.45 Mn 1.45 Mn - -982,444.00
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 1,477.00
Jan 31, 2026 1,741.00
Oct 31, 2025 169.00
Jul 31, 2025 -101.00
Apr 30, 2025 -1,218.00
Jan 31, 2025 2,042.00
Oct 31, 2024 305.00
Jul 31, 2024 1,087.00
Apr 30, 2024 559.00
Jan 31, 2024 -2,992.00
Oct 31, 2023 -1,790.00
Jul 31, 2023 -2,121.00
Apr 30, 2023 516.00
Jan 31, 2023 -2,361.00
Oct 31, 2022 -414.00
Jul 31, 2022 719.00
Apr 30, 2022 61.00
Jan 31, 2022 1,170.00
Oct 31, 2021 -164.00
Jul 31, 2021 -927.00